CTSO Stock Summary and Trading Ideas (Cytosorbents | NASDAQ:CTSO)

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

What symbol and exchange does Cytosorbents shares trade?

Cytosorbents trades on the NASDAQ stock market under the symbol CTSO.

What is Cytosorbents stock price doing today?

As of March 4, 2026, CTSO stock price declined to $0.79 with 48,572 million shares trading.

What is Cytosorbents's Beta?

CTSO has a beta of 0.68, meaning it tends to be less sensitive to market movements. CTSO has a correlation of 0.03 to the broad based SPY ETF.

How much is Cytosorbents worth?

CTSO has a market cap of $49.58 million. This is considered a Sub-Micro Cap stock.

How much money does Cytosorbents make?

Last quarter Cytosorbents reported $9 million in Revenue and -$.04 earnings per share. This fell short of revenue expectation by $-458,400 and exceeded earnings estimates by $.01.

What is the highest and lowest price Cytosorbents traded in the last 3 year period?

In the last 3 years, CTSO traded as high as $4.29 and as low as $.60.

What are the top ETFs holding Cytosorbents?

The top ETF exchange traded funds that CTSO belongs to (by Net Assets): VTI, VXF, IWC, MSSM.

Is Cytosorbents (CTSO) a good investment?

CTSO has underperformed the market in the last year with a return of -23.3%, while SPY returned +18.6%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in CTSO shares. However, CTSO has outperformed the market in the last 3 month and 2 week periods, returning +8.2% and +23.4%, while SPY returned +0.5% and +0.3%, respectively. This indicates CTSO has been having a stronger performance recently.

What are the support and resistance levels for Cytosorbents (CTSO)?

CTSO support price is $.75 and resistance is $.85 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CTSO shares will trade within this expected range on the day.